The challenge of discriminating between HIV-1, HIV-2 and HIV-1/2 dual infections.
Bo Langhoff HøngeS JespersenC MedinaD S TéZ J da SilvaM ChristiansenB KjerulffA L LaursenChristian Morberg WejseH KrarupC Erikstrupnull nullPublished in: HIV medicine (2018)
There was accordance between INNO-LIA calls and nucleic acid results, whereas ImmunoComb overestimated the number of HIV-1/2 dually infected patients. Confirmatory typing is needed for patients diagnosed with HIV-1/2 dual infection by ImmunoComb.